Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.20 is 92% below its 5-year average of 2.50, near the low end of its 5-year range (0.06–62.34).
As of the fiscal period ended Tuesday, June 30, 2026. 12.37% above its 12-month average of 0.18.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.20.
QUICK RATIO (ACID-TEST)
0.20
QUICK RATIO (ACID-TEST) AVG TTM
0.18
QUICK RATIO (ACID-TEST) AVG 3Y
0.41
QUICK RATIO (ACID-TEST) AVG 5Y
2.50
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.37%
CURRENT VS 3Y AVG
-51.52%
CURRENT VS 5Y AVG
-92.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 772 covered companies
CURRENT VS SECTOR MEDIAN
-93.83%
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$19.55M
Quick Ratio (Acid-Test)
0.20
TTM Avg
0.18
3Y Avg
0.41
5Y Avg
2.50
Market Cap
$18.65M
Quick Ratio (Acid-Test)
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$18.97M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.30
3Y Avg
0.39
5Y Avg
0.60
Market Cap
$18.95M
Quick Ratio (Acid-Test)
3.47
TTM Avg
5.82
3Y Avg
11.52
5Y Avg
18.07
Market Cap
$17.65M
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.83
3Y Avg
1.35
5Y Avg
1.29
Market Cap
$19.77M
Quick Ratio (Acid-Test)
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$17.30M
Quick Ratio (Acid-Test)
11.48
TTM Avg
10.71
3Y Avg
12.62
5Y Avg
10.43
Market Cap
$17.01M
Quick Ratio (Acid-Test)
6.03
TTM Avg
7.38
3Y Avg
5.70
5Y Avg
5.02
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $19.55M | 0.20 | 0.18 | 0.41 | 2.50 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 27.85 | 15.71 | 9.25 | 10.43 |
| P3 Health Partners Inc. (PIII)vs › | $18.97M | 0.46 | 0.30 | 0.39 | 0.60 |
| NextCure, Inc. (NXTC)vs › | $18.95M | 3.47 | 5.82 | 11.52 | 18.07 |
| Cosmos Health Inc. (COSM)vs › | $17.65M | 0.92 | 0.83 | 1.35 | 1.29 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.77M | 1.25 | 1.72 | 2.15 | 2.15 |
| PAVmed Inc. (PAVM)vs › | $16.98M | 1.19 | 0.11 | 0.43 | 2.24 |
| Lipocine Inc. (LPCN)vs › | $17.30M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 6.03 | 7.38 | 5.70 | 5.02 |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | 4.61 | 2.49 | 1.75 | 2.54 |
Quick Ratio
0.20
Excludes inventory
Current Ratio
0.20
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.20 |
| 2026-03-31 | 0.24 |
| 2025-12-31 | 0.12 |
| 2025-09-30 | 0.15 |
| 2025-06-30 | 0.16 |
| 2025-03-31 | 0.22 |
| 2024-12-31 | 0.55 |
| 2024-09-30 | 0.75 |
| 2024-06-30 | 24.65 |
| 2024-03-31 | 62.34 |
| 2023-12-31 | 11.17 |
| 2023-09-30 | 1.58 |
| 2023-06-30 | 0.09 |
| 2023-03-31 | 0.07 |
| 2022-12-31 | 0.64 |
| 2022-09-30 | 0.22 |
| 2022-06-30 | 0.83 |
| 2022-03-31 | 14.18 |
| 2021-12-31 | 8.42 |
| 2021-09-30 | 7.75 |
| 2021-06-30 | 0.06 |
| 2021-02-28 | 0.19 |
